Content Type: Article

  • Tax Cuts and Jobs Act of 2017: Impact on Executive Pay of Tax-Exempt Organizations

    ARTICLE

    Tax Cuts and Jobs Act of 2017: Impact on Executive Pay of Tax-Exempt Organizations

    August 2018

    Read time: 2 min

    Key takeaways
    Overview

    Mary Samsa authored this bylined article on the new excise tax on nonprofit executive pay over a certain threshold. “Now is the time for tax-exempt organizations to identify who their covered employee group is . . . and review every component of their compensatory offerings to each covered employee to determine whether any opportunities exist for redesigning or restructuring the underlying arrangement,” she wrote.

    In depth
    Authors
    More insights

  • New York City Commission on Human Rights Issues Poster and Fact Sheet in Compliance with Recently Enacted New York City Anti-Harassment Law

    New York City Commission on Human Rights Issues Poster and Fact Sheet in Compliance with Recently Enacted New York City Anti-Harassment Law

    ARTICLE / CLIENT ALERT

    New York City Commission on Human Rights Issues Poster and Fact Sheet in Compliance with Recently Enacted New York City Anti-Harassment Law

    August 16, 2018

    Read time: 3 min

    Key takeaways
    Overview

    In April 2018, New York State and New York City enacted legislation to combat sexual harassment and sexual assault in the workplace. We discussed the new legislation in a prior SRZ Alert.[1] Among other requirements, the Stop Sexual Harassment in NYC Act (“Act”) provides that employers must display an “anti-sexual harassment rights and responsibilities” poster and distribute information to all employees regarding their rights and responsibilities under federal, state and local anti-harassment laws. On Aug. 10, 2018, the New York City Commission on Human Rights (“Commission”) issued a poster that satisfies the Act’s English-language poster requirement.[2] Employers will also be required to display a Spanish-language version, which the Commission has not yet issued. New York City employers must begin displaying the poster beginning Sept. 6, 2018.

    The Commission also issued a “fact sheet” that satisfies the notice requirement under the Act.[3] Employers may provide the generic fact sheet or incorporate the information into their handbook or stand-alone anti-harassment policies, provided that they distribute the information to all employees. Similar to the poster requirement, New York City employers must comply with this requirement beginning Sept. 6, 2018.

    As we discussed in the prior SRZ Alert,[4] as part of the new legislation, New York State and New York City have mandated anti-harassment and discrimination training. The State and City are expected to issue guidance on what employers may do to comply with the training requirements, as well as model training programs. The State’s and City’s annual training requirement goes into effect on Oct. 9, 2018 and April 1, 2019, respectively. The State is also expected to issue a model harassment and discrimination complaint form.

    Authored by Holly H. Weiss.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or the author.


    [1] and [4] See “New York State and City to Mandate Anti-Sexual Harassment Training for Private Employers,” SRZ Alert, April 12, 2018, available here.

    [2] See poster available here.

    [3] See fact sheet available here.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2018 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Holly H. Weiss

    Retired Partner

    New York – 919 Third Avenue

    More insights

  • Illinois Captive Insurance Regulatory and Tax Reform

    Illinois Captive Insurance Regulatory and Tax Reform

    ARTICLE / CLIENT ALERT

    Illinois Captive Insurance Regulatory and Tax Reform

    August 16, 2018

    Read time: 7 min

    Key takeaways
    Overview

    A captive insurance and self-procurement tax law is awaiting the governor’s signature in Illinois. This new business-friendly law may provide a substantially improved environment for Illinois-based companies looking for captive solutions.

    In depth

    Illinois Governor Bruce Rauner has until August 28 to sign or veto Senate Bill 1737 (Bill), a proposed new law that would reform the Illinois Insurance Code’s regulatory framework for captive insurance companies and significantly drop the state’s current premium tax rate on self-procured insurance. The Illinois General Assembly passed the Bill on May 31, 2018 with bi-partisan support. The Illinois Department of Insurance, key industry groups and several large Illinois-based taxpayers also support the legislation.

    Improved Regulation of Illinois-Licensed Captives

    If it becomes law, the Bill would create a much more favorable regulatory framework for Illinois captives, following the lead of multiple jurisdictions, including Vermont, Hawaii, South Carolina and the District of Columbia. Highlights of the Bill include the following.

    1. Revised minimum capital and surplus requirements

    The Bill would give broad authority to the Illinois Director of Insurance (Director) to set minimum capital and surplus requirements for Illinois licensed captives based on the amount of premium written, the type of assets held by the captive, the terms of reinsurance arrangements, the types of business covered in policies issued by the captive, the underwriting practices and procedures of the captive, and any other criteria that has an impact on the captive deemed significant by the Director. The Bill provides only that the capital and surplus requirements be not less than $250,000 for a “pure” captive insurance company (insuring only the risks of its parent/affiliated companies), $500,000 for an “industrial insured” captive insurance company (insuring the risks of larger insureds with aggregate annual premiums in excess of $100,000, and access to the full-time services of an insurance manager) and $750,000 for an “association” captive insurance company (insuring the risks of the member organizations of an association and their affiliated companies).

    The Illinois Insurance Code (Code) currently requires Illinois-licensed captive insurance companies to meet the minimum capital requirements for Illinois domestic insurers, which are much higher than the minimum levels set forth in the Bill (generally $1 million). See 215 ILCS 5/13. In addition, the Code imposes detailed restrictions regarding how capital must be maintained by captive insurers, requiring in all cases that at least 20 percent be held in cash or cash equivalents. 215 ILCS 5.132C-3(B). In contrast, the Bill would permit captives to meet the minimum capital and surplus requirements via an irrevocable bank letter of credit approved by the Director, Illinois bonds or by US-backed securities.

    2. Expanded scope of representation

    The Bill authorizes Illinois-licensed captives to write insurance covering the risks of a “controlled unaffiliated business,” in addition to the risks of a captive’s affiliates. A “controlled unaffiliated business” is defined as an unaffiliated entity with whom an affiliate of the captive has a contractual relationship under which the affiliate bears a potential financial loss and whose risks are managed by the captive insurer pursuant to standards that may be established by the Director.

    3. Expanded coverage

    The Bill authorizes Illinois-licensed captive insurance companies to issue contractual reimbursement policies to affiliated certified self-insurers authorized under the Illinois Workers’ Compensation Act or an analogous law of another state, as well as affiliates that are insured by workers’ compensation insurance policies with a negotiated deductible endorsement. In contrast, the Code currently provides that Illinois captives can insure an employers’ liability to its employees only to the extent there is legal liability under the Federal Employers’ Liability Act. 215 ILCS 5/123C-2(A)(4)(iii).

    4. Enhanced lending capability

    The Bill provides enhanced lending flexibility to Illinois-licensed captive insurance companies, providing that, with the prior approval of the Director, the captives may make loans to their affiliates, although not of the minimum capital and surplus amounts required by the Bill.

    5. Accepting and ceding risks to a captive reinsurance pool

    The Bill authorizes Illinois licensed captives, with the approval of the Director, to accept risks from and cede risks to or take credit for reserves on risks ceded to an approved affiliated captive insurer or a captive reinsurance pool. The affiliated captive insurer must be licensed to operate in Illinois or by a similar law of another jurisdiction; similarly, any captive reinsurance pool must be composed of other captive insurance companies licensed to operate in Illinois or by a similar law of another jurisdiction.

    6. Significant rate drop for self-procured insurance

    The Bill also substantially drops the premium tax rate for contracts of insurance independently procured directly from an unauthorized insurer by an industrial insured (self-procured insurance) from 3.5 percent to 0.5 percent of gross premium. The tax is imposed on the insured, although it may be deducted from an insured’s premium payments. Insureds subject to the tax would continue to be subject the Surplus Lines Association of Illinois’ countersigning/stamping fee (currently .125 percent of gross premium) and any applicable Illinois Fire Marshall tax.

    If it becomes law, the Bill would take effect for policies with an effective date on or after January 1, 2018. The Bill effectively drops the self-procured insurance tax rate from the surplus lines insurance rate (215 ILCS 5/445(3)(a)(ii)) to the rate imposed on most Illinois domestic admitted insurance companies. (215 ILCS 5/412).

    The current Illinois’ self-procured insurance tax was roundly criticized when it first took effect in January 2015, due to the potential tax burden it created for Illinois home state companies. (See our prior coverage.) While the Bill does not eliminate the tax, as some proponents had hoped, it significantly reduces the burden of the tax by dropping the rate to match Illinois admitted insurer levels. It is also significantly lower than the rate imposed by many other states that instituted a tax on self-procured insurance in response to Congress’s 2011 enactment of the Nonadmitted and Reinsurance Reform Act (NRRA), which provided that a company’s home state—typically its principal place of business—had exclusive authority to tax and regulate nonadmitted insurance. See 15 USC § 8201.

    Comment

    Illinois’ underdeveloped captive law and its high self-procurement tax rate have meant that Illinois has never been a viable option as a captive jurisdiction, even for large Illinois headquartered companies with pure single parent captives. The Bill, if enacted, will be a positive step forward, and will certainly warrant consideration by Illinois-based enterprises that have previously had no real option but to locate their captives elsewhere. Whether Illinois is able to become a favored captive jurisdiction remains to be seen and will depend upon whether the Department acts in a supportive manner in adopting regulations, handling applications and providing interpretations, as well as whether service provider infrastructure develops. Fortunately, many captive service providers already have a presence in Chicago and other Illinois locations. We view this Bill as an important and exciting development for the captive community, and strongly support its enactment.

    Authors

    Lisa M. Kaderabek

    Counsel

    Chicago

    Mary Kay Martire

    Partner

    Chicago

    More insights

  • No Help From Presumption Of Innocence

    ARTICLE

    No Help From Presumption Of Innocence

    August 15, 2018

    Read time: 1 min

    Key takeaways
    Overview

    Dr. Thomas Gennert with article about what happens to a board member taken in custody.

    In depth
    Authors

    Dr. Thomas Gennert

    Partner

    Düsseldorf

    More insights

  • CMS to Allow Medicare Advantage Organizations to Utilize Step Therapy for Part B Drugs

    CMS to Allow Medicare Advantage Organizations to Utilize Step Therapy for Part B Drugs

    ARTICLE / CLIENT ALERT

    CMS to Allow Medicare Advantage Organizations to Utilize Step Therapy for Part B Drugs

    August 15, 2018

    Read time: 6 min

    Key takeaways
    Overview

    The Centers for Medicare & Medicaid Services recently announced that, in a reversal of prior policy, it will begin to allow Medicare Advantage organizations (MAOs) to implement step therapy for Part B drugs and services as of January 1, 2019. There are a number of restrictions on MAOs’ ability to take advantage of this new policy, however. Most notably, MAOs must pair step therapy for Part B drugs with drug management care coordination programs and offer rewards that incentivize beneficiary participation in such programs that are equal to at least half the amount saved on average per participant.

    In depth

    The Centers for Medicare & Medicaid Services (CMS) recently announced its decision to allow Medicare Advantage organizations (MAOs) to implement step therapy for Part B drugs and services beginning January 1, 2019. The agency simultaneously rescinded guidance that was issued in September 2012 prohibiting the practice. Notably, MAOs that choose to take advantage of this option must offer, and encourage enrollees to participate in, a drug management care coordination program. Enrollees who choose to participate in such a program must receive rewards and incentives from the MAO equal in value to at least half of the planned per participant savings from the program.

    CMS explained that its new guidance is based on Section 1852 of the Social Security Act, which allows MAOs to implement utilization management tools. In its 2012 guidance, the agency stated that it interpreted its regulations under 42 CFR 422.101 to prohibit step therapy for Part B drugs unless such step therapy was specifically permitted under a national coverage determination (NCD) or a local coverage determination (LCD). In the recently released guidance, based on the agency’s statutory interpretation, CMS now advises MAOs that step therapy is permitted for Part B drugs where the NCD or LCD is silent on the use of step therapy.

    CMS imposes a number of caveats on MAOs’ ability to take advantage of this new policy:

    • Incentives and Rewards for Drug Management Care Coordination Participation. Perhaps most notably, MAOs must pair step therapy for Part B drugs with drug management care coordination services and rewards that incentivize beneficiary participation in such programs. CMS defines such programs and activities to include, at a minimum:
      • Interactive medication review and associated consultations for enrollees to discuss all current medications and perform medication reconciliation and follow-up when necessary
      • Provision of educational materials and information to enrollees about drugs within the drug management care coordination program
      • Implementation of medication adherence strategies to help enrollees with their medication regimen

    MAOs must offer beneficiaries rewards in exchange for participation in these programs; such rewards can be gift cards or other items of value, but cannot be cash or monetary rebates. A US Department of Health and Human Services press release indicates such rewards could also be offered in the form of lower cost-sharing or, beginning in 2020, lower premiums.

    In order for the reward to be “reasonable and appropriate” and thus permissible, the reward must be “equivalent to more than half the amount saved on average per participant by a more efficient use of health care resources, promotion of improved health, or prevention of injuries and illness.” The guidance does not explicitly state that the total projected savings amount is based on the total amount projected to be saved by implementing Part B step therapy. Instead the guidance is more vague, and simply says the amount of the reward must be based on the savings expected from each participant in the broader drug management care coordination activities. The guidance also does not address how such a drug management care coordination program, or the related savings, would be calculated for beneficiaries enrolled in only Part C coverage without Part D coverage. CMS stated that it will consider rulemaking regarding step therapy for CY 2020, so future guidance may provide greater clarity regarding the rewards and incentive calculation and the drug management care coordination program requirements.

    MAOs must report to CMS the value of the offered rewards or incentives on a per member basis in comparison to the average planned per participant savings from the drug management care coordination activities.

    • Interaction of Part B and Part D Drugs. MAOs offering both Part C and Part D benefits (MAPD Plans) may also use step therapy to require Part D therapy before Part B therapy or vice versa. With respect to the latter, MAPD plans must ensure that such step therapy policies are clearly outlined in their Part D prior authorization criteria for relevant Part D drugs. In order to enable MAPD plans to impose step therapy requirements for Part B drugs in CY 2019, CMS will provide a special window for submission of Part B step therapy prior authorization edits from August 17 to 21, 2018. MAPD plans can also make the change during CY 2019 by requesting a negative change during the standard negative formulary change request timeframes.
    • Pharmacy and Therapeutics Committee. MAPDs are “strongly encouraged” to use their pharmacy and therapeutics committees to determine when use of step therapy for Part B drugs is medically appropriate. If the committee is unable to develop and approve the prior authorization in time for the August 17–21 window, MAPDs may submit placeholder criteria.
    • Disclosures. MAOs must disclose that Part B drugs may be subject to step therapy requirements in Annual Notice of Change (ANOC) and Evidence of Coverage (EOC) documents, in addition to more specific disclosure requirements set forth in the HPMS memo; however, MAOs need not update their bid submissions for 2019.
    • Other Limitations. CMS reminds MAOs that any step therapy measures for Part B drugs should not result in increased costs to beneficiaries, that MA plans must provide access to all Part A and Part B benefits, and that beneficiaries must be able to request an exception from a step therapy requirement for a Part B drug. Additionally, MAOs may only apply step therapy to new prescriptions and may not interrupt ongoing drug therapies with step therapy requirements.

    This new policy may have important implications for both MA plans and providers, as it may encourage a shift away from physician-administered Part B drugs and towards Part D drugs, which beneficiaries most often obtain directly from a pharmacy. The policy may pose some challenges with respect to individuals who are enrolled only in Medicare Advantage, without corresponding drug coverage under Part D. Step therapy that requires use of a Part D drug before a Part B drug would not be possible in such a scenario, and it remains to be seen how such scenarios will play out.

    Authors

    Jeremy Earl

    Partner

    Washington, DC

    More insights

  • Fifth Circuit Holds Lease To Be a Secured Loan

    Fifth Circuit Holds Lease To Be a Secured Loan

    ARTICLE / CLIENT ALERT

    Fifth Circuit Holds Lease To Be a Secured Loan

    August 14, 2018

    Read time: 7 min

    Key takeaways
    Overview

    A purported conditional sale agreement “created a security interest rather than a lease,” held the U.S. Court of Appeals for the Fifth Circuit on Aug. 7, 2018. In re Pioneer Health Services Inc., 2018 WL 3747537, *3 (5th Cir. Aug. 7, 2018). Affirming the lower courts’ finding “that the relevant agreements were not ‘true leases,’” the court rejected a bank’s “motion to compel payment under [its] contract as an unexpired lease or an administrative expense.” Id., at *1. The economic substance, not the form of the transaction, was decisive.

    Relevance

    Pioneer confirms why lessors fare better in bankruptcy cases than secured lenders. Although the lender documented the transaction in Pioneer as a lease to get better treatment in any later bankruptcy, the court relied on its economic substance.

    Bankruptcy Code (“Code”) § 365(d)(3) requires a trustee or Chapter 11 debtor-in-possession (“DIP”) to perform its lease obligations pending assumption or rejection of a lease. In contrast, the DIP need not assume a security agreement within a fixed period of time to obtain the benefits of the property it covers. Pac. Express Inc. v. Teknekron Infoswitch Corp., 780 F.2d 1482, 1487 (9th Cir. 1986). A borrower on a secured loan may retain the property “without paying the full agreed price,” and need only “pay enough to give the lender the value of the security interest; if this is less than the balance due on the loan, the difference is an unsecured debt.” In re United Airlines Inc., 416 F. 3d 609, 610 (7th Cir. 2005) (Easterbrook J.).

    When distinguishing a lease from a secured loan, “every appellate court [ruling on] the issue [holds] . . . that substance controls and that only a ‘true lease’ counts as a ‘lease’ under [Code] §365.” United Airlines Inc., 416 F.3d at 612, citing In re PCH Associates, 804 F.2d 193, 198-200 (2d Cir. 1986); In re Pillowtex Inc., 349 F.3d 711, 716 (3d Cir. 2003). According to the Seventh Circuit, “[i]t is unlikely that the Code makes big economic effects turn on the parties’ choice of language rather than the substance of their transaction; why bother to distinguish transactions if these distinctions can be obliterated at the drafter’s will?” United Airlines Inc. 416 F.3d at 612.

    Facts

    The debtor healthcare provider in Pioneer entered into three agreements with the bank’s predecessor (“Bank”) to finance its purchase of equipment and related software to maintain its electronic health records. 2018 WL 3747537, at *1. Two agreements with the Bank were called “conditional sales agreements,” providing “that upon completion of the installment payment plan, title to” the purchased equipment transferred to the debtor. Until it received full payment, the Bank would “retain title to the Equipment for legal and security purposes,” and the debtor authorized the Bank to file appropriate financing statements under state law. Other provisions of these two agreements provided that the debtor was “leasing (and not financing) any software and . . . upon default,” the debtor was required to delete the software, enabling the Bank to terminate any license and disable the software. A third agreement, though, acknowledged that “[the debtor] has entered into a financing agreement” with the Bank. Finally, the Bank filed an appropriate financing statement under applicable state law. Id., at *1 – 2.

    When the debtor sought Chapter 11 relief, the Bank moved to compel payment from the debtor under the purported leases, arguing that payments were also “actual, necessary costs of preserving the estate” and “actual, necessary costs and expenses of preserving or transferring patient records during the closing [of the debtor’s] healthcare business.” Id., at *2. The bankruptcy court denied the motion, reasoning that the relevant agreements were not “true leases.” The district court affirmed.

    The Fifth Circuit

    Security Interest, Not a Lease. First, the court applied Utah’s version of the Uniform Commercial Code (“UCC”) to “determine whether [the] contract is in fact a lease.” Id. “If a lease is merely a disguised sale and security interest, Code § 365 [governing leases] will not be applicable.” Id., quoting Norton Bankruptcy Law & Practice. § 127:8 (3d ed. 2018 update). Under Utah law, when the agreement is “in the form of a lease,” it will be a secured transaction if it “is not subject to cancellation by the lessee,” and “the lessee . . . is bound to become the owner of the goods.” Id., at *3, quoting Utah Code § 70-1a-203(2)(b) and LMV Leasing Inc. v. Conlin, 805 P. 2d 189, 194 (Utah Ct. App. 1991).

    The Bank relied on language in its “Conditional Sales Agreements”; it “is leasing (and not financing) the software” and has “the right to end its use of the software if [the debtor] fails to pay.” Id. But the “lease” was “non-cancellable” and could not be “terminated for any reason.” On “completion of the payment plan,” title to the “Equipment” would pass to the debtor. Because “Utah law elevates substance over form, moreover, the parties’ labels are not the key consideration,” and “no further analysis is required” to find “a security interest rather than a lease.” Id., quoting Bd. of Equalization of Salt Lake City v. First Sec. Leasing Co., 881 P.2d 877, 878 (Utah 1994). See United Airlines, 416 F. 3d at 617 (“Reversion without additional payment is the UCC’s per se rule for identifying secured credit”). And without “further analysis,” the Fifth Circuit affirmed the lower courts’ finding of a security interest in Pioneer.

    No Administrative Expense. Code § 503(b)(i)(A) gives a creditor an administrative priority claim for “the actual, necessary costs and expenses of preserving the estate.” But the Fifth Circuit, like other courts “impose[s] a temporal limitation: the costs and expenses must have arisen post-[bankruptcy] through a transaction with the” DIP. In re Jack/Wade Drilling Inc., 258 F.3d 385, 387 (5th Cir. 2001).

    The Bank’s transaction with Pioneer “arose years before . . . bankruptcy.” Id., at *4. And because the transaction was “a financing arrangement,” not a lease, the Bank’s claim was “an old expense to be adjusted” under a Chapter 11 reorganization plan. Id., citing United Airlines, 416 F.3d at 613 (each payment on a true lease is a “new expense [that] pay[s] for new inputs”).

    Comments

    1. The Seventh Circuit explained why courts disregard form for economic substance in the lease context. “. . . [R]ent that represents the cost of funds for capital assets or past operations rather than ongoing inputs into production has the quality of debt, and to require such obligations to be assumed under [Code] § 365 to retain an asset would permit financial distress from past operations to shut down a firm that has a positive cash flow from current operations.” United Airlines, 416 F. 3d at 163.
    2. The Seventh Circuit also explained in United Airlines what was at stake in Pioneer: “The question under § 365 is whether [the DIP] must pay in full to enjoy contained [use] or whether, instead, it may reduce payments to the value of the interest secured by the leasehold and treat the residue as unsecured debt.” As in United Airlines, the Fifth Circuit in Pioneer held the Bank’s secured claim subject to treatment under the debtor’s Chapter 11 reorganization plan.

    Authored by Michael L. Cook.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or the author.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2018 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • New Restrictions on Using Non-Competes in Massachusetts – What You Need to Know

    New Restrictions on Using Non-Competes in Massachusetts – What You Need to Know

    ARTICLE / CLIENT ALERT

    New Restrictions on Using Non-Competes in Massachusetts – What You Need to Know

    August 13, 2018

    Read time: 6 min

    Key takeaways
    Overview

    The Massachusetts legislature’s recent approval of a comprehensive non-competition reform bill includes significant restrictions for employers seeking to impose non-compete obligations on Massachusetts workers. The Massachusetts Noncompetition Agreement Act will become effective on October 1, 2018, leaving little time for employers to consider what actions to take to protect their business interests.

    In depth

    Employers will now face significant restrictions when seeking to impose non-compete obligations on Massachusetts workers. The Massachusetts legislature recently approved a comprehensive non-competition reform bill and Governor Charles Baker signed it into law late last week. The Massachusetts Noncompetition Agreement Act (the Act) will become effective on October 1, 2018, which does not leave much time for employers to consider what actions to take to protect their business interests.

    This note briefly addresses what you need to know now about the Act. We will be providing a more detailed analysis of the Act and its practical implications shortly. We will also host both a webinar and a live breakfast seminar in our Boston office in September to provide additional opportunities to learn about the Act and ask questions about its impact; the details for these programs will be announced shortly.

    Can an Employer Still Use Non-Competes in Massachusetts?

    Yes, but only under certain circumstances. The Act imposes several new requirements for a non-compete to be valid and enforceable in Massachusetts, which include that:

    • The restricted period cannot be longer than one year after termination (or up to two years for certain bad actors);
    • The non-compete must be supported by continued payment of at least 50 percent of base salary during the restricted period or “other mutually-agreed upon consideration,” the amount of such consideration or when it is to be paid are not addressed in the Act;
    • The non-compete cannot be enforced against an employee who is laid off or terminated without cause if it is entered into other than in connection with employment termination – what constitutes “cause” is not defined in the Act;
    • The employer must comply with new procedural rules in connection with signing a non-compete intended to protect employees (e.g., notice periods, right to consult with counsel);
    • Continued employment cannot be used as consideration to support a non-compete with a current employee;
    • The non-compete cannot be broader than is necessary to protect the employer’s trade secrets, confidential information or goodwill, and must be consistent with public policy; and
    • Only salaried employees may be covered by a non-compete.

    These minimum requirements represent a departure from existing law. Few, if any, existing non-competition agreements will meet all of these requirements.

    Does the Act Restrict Use of Non-Solicitation and Confidentiality Agreements?

    No, employers may still use (i) covenants not to solicit employees, customers, clients or vendors of the employer; (ii) confidentiality agreements; and (iii) invention assignment agreements.

    Are Independent Contractors Covered under the Act?

    Yes, the non-compete restrictions under the Act cannot be avoided by structuring services under an independent contractor relationship.

    What about Non-Compete Forfeiture Provisions in Compensation Arrangements?

    The Act treats any agreement that imposes “adverse financial consequences” on a former employee who engages in competitive activities as a form of non-competition agreement. As a result, unless the minimum requirements noted above are met, the Act prohibits an employer from forfeiting previously accrued compensation due to a non-compete breach. It is quite common for employers to include non-compete forfeiture provisions in equity awards, deferred compensation arrangements and supplemental pensions. The Act would not affect service and performance based vesting conditions or bad boy clauses unrelated to non-compete obligations.

    Our Business is Headquartered Outside of Massachusetts – Can’t We Just Provide That the Law of Our Home Stated Governs the Non-Compete to Avoid These Restrictions?

    The Act contemplates that employers may try to use choice of law provisions to avoid the new minimum requirements. Massachusetts will refuse to honor a choice of law provision with respect to an employee who is, and has been for at least thirty days immediately before termination of employment, a resident of or employed in Massachusetts at the time of employment termination. This provision appears to apply to an employee who has recently moved to Massachusetts from another jurisdiction. In addition, the Act states that all civil actions relating to covered non-competition agreements be brought in the county where the employee resides or, if mutually agreed by the employer and employee, in the Superior Court of Suffolk County.

    Will Existing Non-Competition Agreements Need to Be Amended to Comply with These Changes?

    Generally, no. The Act only applies to non-competition agreements entered into on or after October 1, 2018. However, it remains to be seen whether amendments to a non-competition agreement on or after October 1st might cause it to become subject to the new non-compete restrictions under the Act.

    Will a New Non-Competition Agreement Entered into before October 1, 2018 Be Exempt from These New Restrictions?

    It seems that the answer is yes. There is nothing in the Act that covers new non-competition agreements entered into before October 1, 2018. However, it remains to be seen how courts might be influenced by the Act with respect to agreements that do not comply with the new minimum requirements (e.g., non-competes longer than 12 months).

    What about Non-competition Agreements Made in Connection with the Sale of a Business?

    Non-competition agreements made in connection with sale of a business may be enforceable against a “significant owner” of the business who will receive “significant consideration or benefit from the sale” without meeting the new minimum non-compete restrictions described above.

    Bottom Line

    It remains to be seen how all of this will affect the ultimate enforceability of any particular non-compete provision in court. Assuming that all of the new technical drafting requirements are met, the standard for enforceability remains as it has for more than 30 years in Massachusetts: the agreement will be enforced only to the extent necessary to protect trade secrets, confidential business information or goodwill. This is, and always will be, an incredibly fact-intensive analysis.

    Authors

    Andrew C. Liazos

    Partner

    Boston, New York – One Vanderbilt Avenue

    More insights

  • New FIRRMA Legislation Amending CFIUS Will Soon Be Signed into Law

    New FIRRMA Legislation Amending CFIUS Will Soon Be Signed into Law

    ARTICLE / CLIENT ALERT

    New FIRRMA Legislation Amending CFIUS Will Soon Be Signed into Law

    August 10, 2018

    Read time: 6 min

    Key takeaways
    Overview

    The Foreign Investment Risk Review Modernization Act (FIRRMA) is expected to be signed into law by President Trump in the coming days. FIRRMA updates and expands the role of the Committee on Foreign Investment in the United States (CFIUS). FIRRMA could start applying as soon as September 2018, although most of its provisions will become effective only once CFIUS adopts regulations.

    Among key changes to the current system, FIRRMA will expand the scope of the transactions that may be reviewed by CFIUS (including new coverage for certain investment fund investments), provide for mandatory filings in certain circumstances, extend the review period, allow parties to file short-form declarations in many types of transactions, and provide for a filing fee. FIRRMA directs that the US Secretary of Commerce report every two years to Congress and CFIUS specifically on Chinese foreign direct investments.

    Companies planning transactions or investments pursuant to which a foreign party would acquire an interest in a US business should carefully consider and take appropriate steps to address whether and how the deal would be treated by CFIUS, as amended by FIRRMA.

    In depth

    We reported on July 11, 2018, that a bipartisan group from the US Senate and the House of Representatives had introduced legislation to update and expand the role of the Committee on Foreign Investment in the United States (CFIUS) in reviewing possible US national security implications of acquisitions and investments in US businesses by foreign parties.

    On August 1, 2018, the Senate approved a final version of the Foreign Investment Risk Review Modernization Act (FIRRMA) and the bill is now expected to be signed into law by the president in the coming days. The new legislation was passed by the US Congress as part of a broader national defense authorization bill (the National Defense Authorization Act, which also includes a section updating the US export controls laws).

    FIRRMA could apply as soon as sometime in September 2018, within 30 days of its signing into law. Most of FIRRMA will not take effect for several months, however, and will become effective only once CFIUS writes and implements new regulations, which will require a comment and review process with stakeholders.

    FIRRMA will apply in full to any transaction “proposed, pending, or completed” within 30 days after CFIUS indicates its new regulations and related resources are in place. Any transaction still pending (i.e., not closed) by that time that was not already filed under the current CFIUS rules and procedures will become subject to the new regulations.

    FIRRMA will affect pending transactions that involve an acquisition of or an investment in a US business by a foreign company. We detail below some of the key changes to the current system:

    • Expanded Scope of “Covered Transactions”

    CFIUS will maintain its current right to review transactions that give foreign companies control over or access to a sensitive US asset, but FIRRMA will expand the scope of “covered transactions” beyond foreign parties’ acquisition of control over US businesses to include:
    (1) Certain real estate transactions (such as purchases, leases and concessions) involving land close to sensitive US facilities (such as military or national security facilities);
    (2) Certain investments in “critical infrastructure” businesses;
    (3) Investments in businesses that maintain or collect personal data of US citizens;
    (4) Investments in businesses that develop, make, or test “critical technologies.” “Critical technologies” are not precisely defined in the legislation, but could include technologies that are subject to US export controls and other security controls, including new export control provisions in the legislation designed to protect “emerging and foundational technologies.” Reports indicate that among the emerging technologies considered “critical” will be artificial intelligence, robotics, biotechnology, and similar areas;
    (5) Changes in rights of a foreign company with respect to its investment in a US business; and
    (6) Transactions that are structured in a manner to avoid CFIUS review (such as through a complex investment vehicle).

    • Mandatory Filings

    Filings (declarations) will be mandatory (not voluntary, as under current rules) for transactions involving an investment (1) by a foreign person in which a foreign government has a “substantial interest,” (2) resulting in the direct or indirect acquisition of a “substantial interest” in a US critical infrastructure business, critical technology business, or US business that maintains sensitive personal data of US citizens. The term “substantial interest,” used in both of the foregoing contexts, must still be defined by CFIUS in new regulations. Mandatory declarations will not be required for investments by US investment funds.

    • Extension of Review Period

    Today, the CFIUS review process consists of a 30-day initial review period, potentially followed by a 45-day investigation period. FIRRMA will extend the initial CFIUS review period from 30 days to 45 days, with an additional 15-day period extension for “extraordinary circumstances” (to be defined by CFIUS regulations). As a practical matter, CFIUS reviews have been extended beyond the 30-day period already, with CFIUS moving many reviews into the 45-day investigation stage to allow more time. In addition, in several cases, CFIUS has asked parties to withdraw their filings and refile multiple times with the same intent of extending the Committee’s time to review a deal.

    • Short-Form Declarations

    FIRRMA will allow for parties in many types of transactions to file short-form declarations (up to only five pages) containing basic information regarding the transaction. Within this 30-day period, CFIUS will inform the parties whether a full review is needed, in which case the parties will need to file a written notice of their transaction.

    • Filing Fee

    Under current law, there is no CFIUS filing fee. FIRRMA will provide for a filing fee, up to the lesser of 1 percent of the value of the transaction or $300,000 (adjusted annually).

    FIRRMA will impact a wide range of new foreign acquisitions and investments in the United States. The general intent and broadening scope of CFIUS under FIRRMA may also result in an immediate heightened level of scrutiny of any foreign investments and acquisitions of US businesses that are not notified to CFIUS.

    Companies planning transactions or investments pursuant to which a foreign party would acquire an interest in a US business should carefully consider and take appropriate steps to address whether and how the deal would be treated by CFIUS, as amended by FIRRMA. Certain Chinese investments may particularly be scrutinized. Though FIRRMA does not expressly focus on China, except for the biennial reporting requirement noted above, Congressional and Trump Administration concern about Chinese access to sensitive US technology has influenced passage of FIRRMA.

    Many details and key definitions will still need to be specified by CFIUS in new regulations. Companies will be able to engage with CFIUS during its rulemaking process. Companies should monitor these developments and take them into account when considering US investment and acquisition opportunities.

    Authors

    David J. Levine

    Senior Counsel

    Washington, DC

    Raymond Paretzky

    Counsel

    Washington, DC

    More insights

  • AI Is a Litigation Force Multiplier

    AI Is a Litigation Force Multiplier

    ARTICLE

    AI Is a Litigation Force Multiplier

    August 2018

    Read time: 2 min

    Key takeaways
    Overview

    Martha Louks, director of technology services for McDermott Discovery, authored this bylined article on how artificial intelligence (AI) can benefit e-discovery. “In our experience, strategic and creative uses of AI have been extremely successful in reducing the costs associated with e-discovery, as well as helping counsel find the most important information in a large set of documents very quickly,” she wrote.

    In depth
    Authors

    Martha K. Louks

    Director of Technology Services

    Washington, DC

    More insights

  • Eligibility Requirements For Reduced Tax Rate On FDII For Royalties

    ARTICLE

    Eligibility Requirements For Reduced Tax Rate On FDII For Royalties

    August 9, 2018

    Read time: 2 min

    Key takeaways
    Overview

    David Noren, Lowell Yoder and Elizabeth Chao authored this bylined article on the taxation of royalty income derived from business conducted outside the United States. “A domestic corporation should carefully analyze the royalties it derives from licensing intangible property for use outside the United States and ensure that the FDII requirements are satisfied, and develop documentation supporting the applicability of the 13.125 percent tax rate,” they wrote.

    This column is reprinted with the publisher’s, Wolters Kluwer, permission from Global Tax Weekly, and originally appeared at pages 16-17, August 9, 2018.

    In depth
    Authors

    David G. Noren

    Partner

    Washington, DC

    Lowell D. Yoder

    Partner

    Chicago

    More insights